Victory Square Establishes Venture for Innovation in Personalized Health
VANCOUVER, BRITISH COLUMBIA, CANADA (July 25, 2017) – In a bold move designed to enter a
new era of innovation in the rapidly emerging field of personalized health, Victory Square Technologies
Inc. (“Victory Square” or the “Company”) (CSE: VST)(OTC: VSQTF)(FWB: 6F6) has created a new venture,
Victory Square Health Inc. (“Victory Square Health”).
Victory Square Health will serve as the venture arm dedicated to companies focused on the development
of solutions in personalized health technologies. The Company will have an initial focus on the
management and prevention of diabetes, a condition that affects approximately 1 in 3 individuals globally and over 125 million people in North America alone, according to the Centers for Disease Control & Prevention (CDC) and Diabetes Canada. “Capital, business development, clinical evaluations, medical experts, research, regulatory support and commercialization advisory are all elements critical to success in the health sector, but sometimes they’re challenging for companies to access in a timely fashion, especially in the fast-moving space of technology,” said Shafin Diamond Tejani, President and Chief Executive Officer of the parent company, Victory Square. “There will be no such barriers to innovation at Victory Square Health and among our partner health technology companies in the weeks, months and years to come.”
Through strategic resources and technical development capabilities, Victory Square Health will utilize its
relationships with seasoned industry experts, including Dr. Bruce McManus and Dr. Pieter Cullis, institutions such as the University of British Columbia in Vancouver and Simon Fraser University in Burnaby, B.C., and organizations such as BC Diabetes with leading endocrinologist Dr. Tom Elliott.
“It’s a dynamic space in which to operate and we are optimistic about supporting companies that can do
more than ever before,” added Tejani. “Personalized Health is the future of medicine and the team and
partnerships Victory Square Health has established will allow us to be at the forefront of the rapidly
growing health tech industry.”
ABOUT VICTORY SQUARE TECHNOLOGIES INC.
Victory Square is a technology company focused on leading-edge ideas in sports, personalized health and entertainment, including gaming and film. It holds established core competencies in Virtual Reality,
Augmented Reality, Mixed Reality, Artificial Intelligence and Blockchain technology. As a technology
innovator, incubator and accelerator, Victory Square invests in game-changing entrepreneurs who are
provided access to education programs, global mentorship networks, distribution partners, creative
workspaces, resources and other forms of operational support to help them scale internationally. For
more information, please visit www.victorysquare.com.
ABOUT THE CANADIAN SECURITIES EXCHANGE (CSE)
The Canadian Securities Exchange, or CSE, is operated by CNSX Markets Inc. Recognized as a stock
exchange in 2004, the CSE began operations in 2003 to provide a modern and efficient alternative for
companies looking to access the Canadian public capital markets. The CSE has not reviewed, nor approved or disapproved the content of this news release.
For further information about the Company, please contact:
Howard Blank, Director
This news release may include forward-looking information within the meaning of Canadian securities
legislation, concerning the business of Victory Square. Forward-looking information is based on certain
key expectations and assumptions made by the management of Victory Square, including future plans for acquisitions. Although Victory Square believes that the expectations and assumptions on which such
forward-looking information is based are reasonable, undue reliance should not be placed on the forwardlooking information because Victory Square can give no assurance that they will prove to be correct.
Forward-looking statements contained in this news release are made as of the date of this news release.
Victory Square disclaims any intent or obligation to update publicly any forward-looking information,
whether as a result of new information, future events or results or otherwise, other than as required by
applicable securities laws.